Just got this in my email and thought I'd pass it on. Looks like it is going to be used to monitor patients
doing the Sovaldi/Olysio combo for information on how the drug is doing in general population.
This email is to inform you about a clinical study of patients with chronic Hepatitis C. The purpose of this study is to collect blood samples from patients infected with Hepatitis C to measure levels of the virus. The results will be used to evaluate a laboratory test that can be used by doctors to assess a patients response to Hepatitis C medication.
You may be eligible to participate in this study if you:
Have chronic HCV infection
Are about to start treatment with Sovaldi (sofosbuvir)
Are at least 18 years of age
Your participation in this study may help other hepatitis patients in the future manage their disease by developing a laboratory test that is more precise and accurate. Being part of a research study is completely voluntary. You may be compensated for your participation. Additional blood samples would be collected when you see your doctor for regular care.
We appreciate your interest in the study. Please see the map below for study site locations.*
*Multiple site locations in selected city.
For more information this study is listed on http://clinicaltrials.gov with study identifier: NCT02068963.
Hi,
Just got this in my email and thought I'd pass it on. Looks like it is going to be used to monitor patients
doing the Sovaldi/Olysio combo for information on how the drug is doing in general population.
You may be eligible to participate in this study if you:
Your participation in this study may help other hepatitis patients in the future manage their disease by developing a laboratory test that is more precise and accurate. Being part of a research study is completely voluntary. You may be compensated for your participation. Additional blood samples would be collected when you see your doctor for regular care.
We appreciate your interest in the study. Please see the map below for study site locations.*
*Multiple site locations in selected city.
For more information this study is listed on http://clinicaltrials.gov with study identifier: NCT02068963.